HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masami Masuda-Suzukake Selected Research

sarkosyl

1/2022Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
2/2016Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.
2/2016The Abundance of Nonphosphorylated Tau in Mouse and Human Tauopathy Brains Revealed by the Use of Phos-Tag Method.
4/2013Prion-like spreading of pathological α-synuclein in brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masami Masuda-Suzukake Research Topics

Disease

14Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2013
12Dementia (Dementias)
01/2022 - 04/2013
11Multiple System Atrophy
11/2021 - 08/2014
11Synucleinopathies
11/2021 - 04/2013
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2013
8Tauopathies
01/2022 - 01/2012
7Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2018 - 01/2012
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2013
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 01/2012
3Corticobasal Degeneration
01/2022 - 08/2013
3Frontotemporal Dementia (Semantic Dementia)
06/2014 - 01/2012
2TDP-43 Proteinopathies
07/2013 - 01/2012
1Pick Disease of the Brain (Pick's Disease)
01/2022
1Paralysis (Palsy)
11/2021
1Proteostasis Deficiencies
01/2016
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
08/2013

Drug/Important Bio-Agent (IBA)

14SynucleinsIBA
01/2022 - 01/2013
11Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2013
8PrionsIBA
01/2022 - 07/2013
4sarkosylIBA
01/2022 - 04/2013
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2016
3tau Proteins (tau Protein)IBA
01/2020 - 08/2013
3DNA-Binding Proteins (DNA Binding Protein)IBA
01/2018 - 01/2012
3DipeptidesIBA
08/2015 - 10/2013
2Protein Isoforms (Isoforms)IBA
01/2022 - 08/2013
2alpha-SynucleinIBA
01/2019 - 01/2018
2UbiquitinIBA
02/2015 - 07/2013
2Biomarkers (Surrogate Marker)IBA
05/2014 - 01/2013
2EpitopesIBA
08/2013 - 01/2012
1SilverIBA
01/2019
1Protein AggregatesIBA
02/2018
11,3- bis(bis(pyridin- 2- ylmethyl)amino)propan- 2- olIBA
02/2016
1TrypsinIBA
02/2016
1Amyloidogenic ProteinsIBA
01/2016
1EndotoxinsIBA
01/2016
1LipopolysaccharidesIBA
01/2016
1GranulinsIBA
02/2015
1poly(glycyl-alanyl)IBA
06/2014
1AsparagineIBA
08/2013
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2013
1AntibodiesIBA
01/2012
1Peptide Hydrolases (Proteases)FDA Link
01/2012
1Pharmaceutical PreparationsIBA
01/2012
1Methylene Blue (Methylthioninium Chloride)FDA Link
01/2012

Therapy/Procedure

1Oral Administration
11/2021
1Intraperitoneal Injections
11/2021
1Injections
04/2013
1Therapeutics
04/2013